
DIA Labs Canada develops AirSense, a microneedle-based wearable that tracks inflammatory biomarkers in real time to enable early intervention before an asthma attack. The system supports personnel health, reduces medical emergencies, and helps maintain performance during training, deployments, and extreme environmental exposure.